A detailed history of Salvus Wealth Management, LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Salvus Wealth Management, LLC holds 11,691 shares of VIR stock, worth $101,010. This represents 0.05% of its overall portfolio holdings.

Number of Shares
11,691
Previous 11,691 -0.0%
Holding current value
$101,010
Previous $104,000 16.35%
% of portfolio
0.05%
Previous 0.07%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 10, 2023

BUY
$9.14 - $24.62 $106,855 - $287,832
11,691 New
11,691 $109,000

Others Institutions Holding VIR

About Vir Biotechnology, Inc.


  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $1.15B
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Salvus Wealth Management, LLC Portfolio

Follow Salvus Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Salvus Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Salvus Wealth Management, LLC with notifications on news.